- Home
- TERN vs YSS Comparison
TERN vs YSS Comparison
Compare TERN & YSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$52.67
N/A
Current Price
$27.73
Company Overview
Basic Information| Metric | TERN | YSS |
|---|---|---|
| Founded | 2017 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Military/Government/Technical |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.8B | 4.2B |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | TERN | YSS |
|---|---|---|
| Price | $52.67 | $27.73 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 9 |
| Target Price | ★ $46.72 | $36.33 |
| AVG Volume (30 Days) | ★ 9.0M | 1.6M |
| Earning Date | 05-07-2026 | 03-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 8.04 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $48.43 |
| Revenue Next Year | N/A | $52.83 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.04 | $16.93 |
| 52 Week High | $53.19 | $34.36 |
Technical Indicators
Market Signals| Indicator | TERN | YSS |
|---|---|---|
| Relative Strength Index (RSI) | 73.83 | 61.88 |
| Support Level | $38.99 | $24.61 |
| Resistance Level | $53.19 | $29.07 |
| Average True Range (ATR) | 0.90 | 2.64 |
| MACD | -0.15 | 1.03 |
| Stochastic Oscillator | 91.61 | 78.59 |
Price Performance
Historical Comparison TERN
YSS
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.